Novozymes announces that the Board has appointed two new Executive Vice
Presidents for Novozymes' Executive Management, namely Thomas Nagy and Thomas
Videbęk. Arne Schmidt will be retiring with effect from October 1 after 37
years with Novo Nordisk and Novozymes. There will also be a number of
structural changes in the Executive Management and the organization. 

Download the full stock exchange announcement